Darrin Beaupre
Chief Tech/Sci/R&D Officer at IDEAYA BIOSCIENCES, INC.
Net worth: - $ as of 30/03/2024
Profile
Darrin M.
Beaupre is a Chief Medical Officer at IDEAYA Biosciences, Inc. He previously worked as Head-Early Oncology Development at Pfizer Inc., VP-Clinical Medicine & Early Development at Pharmacyclics LLC, and Chief Medical Officer at Biosplice Therapeutics, Inc. He also worked as an Assistant Professor at Moffit Cancer Center.
Beaupre holds a doctorate degree from The University of Texas Medical School At Houston.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IDEAYA BIOSCIENCES, INC.
-.--% | 30/03/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Darrin Beaupre active positions
Companies | Position | Start |
---|---|---|
IDEAYA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 20/11/2022 |
Former positions of Darrin Beaupre
Companies | Position | End |
---|---|---|
Moffit Cancer Center | Corporate Officer/Principal | - |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
PFIZER, INC. | Chief Tech/Sci/R&D Officer | - |
PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Training of Darrin Beaupre
The University of Texas Medical School At Houston | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
IDEAYA BIOSCIENCES, INC. | Health Technology |
Private companies | 3 |
---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Commercial Services |
Moffit Cancer Center |
- Stock Market
- Insiders
- Darrin Beaupre